showed a trendp = 0.067
4h ), where CNO-treated CR AgRP-Gi mice showed a trend toward a ~ 65% decrease compared to vehicle-treated mice (31 ± 13 vs. 10 ± 1 cells/side/section, t-test, p = 0.067, Cohen’s d = 1.05).
4h ), where CNO-treated CR AgRP-Gi mice showed a trend toward a ~ 65% decrease compared to vehicle-treated mice (31 ± 13 vs. 10 ± 1 cells/side/section, t-test, p = 0.067, Cohen’s d = 1.05).